Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial

被引：42
|
作者：
Schneider, LS [1 ]
Ismail, MS [1 ]
Dagerman, K [1 ]
Davis, S [1 ]
Olin, J [1 ]
McManus, D [1 ]
Pfeiffer, E [1 ]
Ryan, JM [1 ]
Sultzer, DL [1 ]
Tariot, PN [1 ]
机构：
[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
来源：
SCHIZOPHRENIA BULLETIN | 2003年 / 29卷 / 01期
关键词：
Alzheimer's disease; atypical antipsychotic; psychosis; dementia; effectiveness;
D O I：
10.1093/oxfordjournals.schbul.a006991
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
This article describes the development of the protocol for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Alzheimer's disease trial, which was developed in collaboration with the National Institute of Mental Health to assess the effectiveness of atypical antipsychotics for psychosis and/or agitation occurring in outpatients with Alzheimer's disease. The article provides a detailed description of the methodology used in the trial as well as the clinical outcomes and effectiveness measures incorporated into it, discussing the most salient issues encountered in developing the design of the trial, as well as the unique features of the trial.
引用
收藏
页码：57 / 72
页数：16
相关论文
共 50 条
  • [1] National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology
    Schneider, LS
    Tariot, PN
    Lyketsos, CG
    Dagerman, KS
    Davis, KL
    Davis, S
    Hsiao, JK
    Jeste, DV
    Katz, IR
    Olin, JT
    Pollock, BG
    Rabins, PV
    Rosenheck, RA
    Small, GW
    Lebowitz, B
    Lieberman, JA
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 9 (04): : 346 - 360
  • [2] Commentary on the clinical antipsychotic trials of intervention effectiveness (CATIE)
    Kane, John M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (05) : 831 - 832
  • [3] Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial
    Swartz, MS
    Perkins, DO
    Stroup, TS
    McEvoy, JP
    Nieri, JM
    Haak, DC
    SCHIZOPHRENIA BULLETIN, 2003, 29 (01) : 33 - 43
  • [4] Evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond
    Nasrallah, Henry A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 : 3 - 4
  • [5] Introduction: An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
    McEvoy, Joseph P.
    CNS SPECTRUMS, 2006, 11 (07) : 4 - 8
  • [6] National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's disease (CATIE-AD): Baseline characteristics
    Ismail, M. Saleem
    Dagerman, Karen
    Tariot, Pierre N.
    Abbott, Shana
    Kavanagh, Sarah
    Schneider, Lon S.
    CURRENT ALZHEIMER RESEARCH, 2007, 4 (03) : 325 - 335
  • [7] The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
    Meyer, JM
    Nasrallah, HA
    McEvoy, JP
    Goff, DC
    Davis, SM
    Chakos, M
    Patel, JK
    Keefe, RSE
    Stroup, TS
    Lieberman, JA
    SCHIZOPHRENIA RESEARCH, 2005, 80 (01) : 9 - 18
  • [8] Prognostic Subgroups for Remission, Response, and Treatment Continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Trial
    Jakubovski, Ewgeni
    Carlson, Jon P.
    Bloch, Michael H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (11) : 1535 - 1545
  • [9] Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
    Volavka, Jan
    Czobor, Pal
    Citrome, Leslie
    Van Dorn, Richard A.
    CNS SPECTRUMS, 2014, 19 (05) : 374 - 381
  • [10] Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: Primary efficacy and safety outcomes of the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial
    Lieberman, JA
    Stroup, TS
    McEvoy, JP
    Swartz, MS
    Rosenheck, RA
    Perkins, DO
    Keefe, RS
    Davis, SM
    Davis, CE
    Lebowitz, B
    Hsiao, J
    Severe, J
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S32 - S32
12345